North China Pharmaceutical: The company has obtained the "Drug Registration Certificate" for injection of isavuconazole sulfate.

On the evening of June 5th, North China Pharmaceutical announced that the company had received the "Drug Registration Certificate" for injection of Isavuconazonium Sulfate approved and issued by the National Medical Products Administration. The indication of this drug is for the treatment of invasive aspergillosis and mucormycosis in adults.